Sponsor:
Joanna Yi
Code:
NCT07059975
Conditions
Acute Myeloid Leukemia
Pediatric AML
Eligibility Criteria
Sex: All
Age: 0 - 30
Healthy Volunteers: Not accepted
Interventions
Idarubicin Hydrochloride
Fludarabine
Cytarabine (Ara-C)
Venetoclax
Etoposide
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-07. This information was provided to ClinicalTrials.gov by Joanna Yi on 2025-11-04.